In more than 60% of all colon cancer, Bcl-xL staining is more pronounced than in normal colon epithelium, whereas Bcl-2 expression was reported to be too low for detection by Northern blotting (Krajewska et al, 1996; Maurer et al, 1998). The gene discussed is BCL2L1; the disease is malignant colon neoplasm.